DUROS [trade mark sign] LEUPROLIDE IMPLANTABLE THERAPEUTIC SYSTEMS IN PATIENTS WITH ADVANCED PROSTATE CANCER: 14-MONTH RESULTS OF A PHASE I/II DOSE-RANGING STUDY
暂无分享,去创建一个
G. Andriole | J. Gottesman | M. Soloway | J. Libertino | S. Bardot | J. Fowler | I. Rivera-Ramirez | P. Bernhard | C. Reid